课题基金 / 基金详情

Mapping the perivascular reticular network in health, aging, and AD

Mapping the perivascular reticular network in health, aging, and AD
绘制健康、衰老和 AD 中的血管周围网状网络图
批准号:
10739104
负责人:
Rupal I. Mehta
金额:
$124.64万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2026-08-31

项目摘要

项目成果

Rupal I. Mehta的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Perivascular space (PVS) pia is a unique tissue composite within the mammalian nervous system and is traversed by cerebrospinal fluid (CSF) during CSF-interstitial fluid exchange. PVS are known to become more complex with aging. Accumulating evidence suggests that PVS subserve specialized roles in glymphatic- lymphatic transport and may be a critical factor in brain resilience and diseases, including Alzheimer’s disease. In spite of this, the basic structure of brain pia is minimally investigated across species. Historically, pia has been perceived to play passive roles as an ultrafine membrane that restricts fluid movement at the brain surface. Substantial gaps in knowledge remain regarding the specific morphology and constituents of this meningeal layer and its associations with disease, due in large part to lack of systematic and high-resolution microscopic analyses. To advance the field, better characterization of pia structure is needed. In this project, high-resolution microscopy techniques will be used to elucidate the morphology of human pia mater and its morphological and compositional changes with aging. Pial anatomy will be mapped using immunohistochemical techniques and its properties will be correlated with established neuropathological and neurological measures of disease. For this work, we will leverage a rich resource of clinical and pathologic material available from the Rush Religious Orders Study and Memory and Aging Project (ROSMAP) and will collect and analyze novel data pertaining to the unique structure of PVS pia. The hypothesis is that PVS pia functions as a critical neuroimmune tissue and that pial senescence is associated with Alzheimer’s disease (AD). In Aim 1, we will examine the associations of pial morphology with intracranial beta-amyloid (βA) accumulation and pathology of AD. In Aim 2, we will examine the associations of pial morphology with cognitive decline and resilience. In Aim 3, we will explore the associations of pial morphology with PVS and brain inflammation. In each aim, we will investigate how relationships differ by age, sex, and comorbid diseases. Overall, these studies have the potential to uncover new knowledge regarding the function of pia mater in aging and AD as well as novel insights into its heterogeneity in aging. The proposed investigations will advance the field and may reveal mechanistic, diagnostic and prognostic factors for AD while laying a framework for studying this meningeal layer in the setting of other age-related neurological diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Arachnoid Granulation Senescence in Aging, CAA and Alzheimer's Disease
  • 批准号:
    10525081
  • 项目类别:
  • 资助金额:
    $43.45万
  • 财政年份:
    2022
  • 负责人:
    Rupal I. Mehta
  • 依托单位:
Alpha-Endosulfine in Post-Ischemic Neuronal Apoptosis
  • 批准号:
    9119209
  • 项目类别:
  • 资助金额:
    $15.41万
  • 财政年份:
    2015
  • 负责人:
    Rupal I. Mehta
  • 依托单位:
Alpha-Endosulfine in Post-Ischemic Neuronal Apoptosis
  • 批准号:
    9145793
  • 项目类别:
  • 资助金额:
    $15.51万
  • 财政年份:
    2015
  • 负责人:
    Rupal I. Mehta
  • 依托单位:
Alpha-Endosulfine in Post-Ischemic Neuronal Apoptosis
  • 批准号:
    8803867
  • 项目类别:
  • 资助金额:
    $15.12万
  • 财政年份:
    2014
  • 负责人:
    Rupal I. Mehta
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: